Bimetron Biotechnology is a Turkey-based startup that focuses on integrating biotechnology and medical engineering to advance healthcare through innovative solutions and treatments for various medical conditions. The company is dedicated to developing affordable and accessible tissue engineering products and cell culture systems with a primary focus on cell-based therapies, 3D cell culture systems, biomaterials, and bioreactors. Bimetron also specializes in designing and producing innovative bioprocess devices to address unmet needs in biomaterial and tissue engineering applications.
In addition to their core focus, Bimetron also develops and produces peristaltic pumps, high-precision liquid injection and liquid sampling systems, temperature control, and mixing devices using smart algorithms. The company aims to provide support for the diverse device needs of the industry while contributing to the advancement of digital health, healthcare, health and wellness, and healthtech.
Founded in 2012, Bimetron Biotechnology is poised to make a significant impact in the healthcare industry by leveraging the potential of biotechnology and medical engineering. Although no specific information regarding the last investment or the involved investors is available at present, the company's dedication to addressing unmet needs in healthcare and bioprocessing presents promising opportunities for potential investors seeking to support innovative and impactful solutions in the evolving landscape of healthcare technology.
There is no investment information
No recent news or press coverage available for Bimetron Biotechnology Medical Electronics Engineering Industry Co., Ltd.